Clinical Trial Update: Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol

View source ↗

Summary

This clinical trial update outlines a study using the PET imaging tracer [18F]Fluoroethoxybenzovesamicol to evaluate cholinergic innervation in Parkinson's dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• [18F]Fluoroethoxybenzovesamicol

Snippet

Sponsor: University Medical Center Groningen | Conditions: Parkinson's Disease | Status: UNKNOWN